Maquet Cardiovascular
16
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.8%
3 terminated/withdrawn out of 16 trials
78.6%
-7.9% vs industry average
0%
0 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
Role: lead
A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (APACAR2)
Role: collaborator
Evaluation of FUSION™ Vascular Graft for Above Knee Targets
Role: lead
Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery Bypass.
Role: lead
Intra-aortic Balloon Pump in Extensive Myocardial Infarction With Persistent Ischemia
Role: collaborator
CardioRoot Post-Marketing Surveillance Registry
Role: lead
MACCE After Endoscopic Vein Harvest for CABG
Role: collaborator
A Pilot Study of Synchronized and Non-invasive Ventilation ("NeuroPAP") in Preterm Newborns
Role: collaborator
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Role: collaborator
Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Role: collaborator
InterGard Synergy Post-Marketing Surveillance Study
Role: lead
Performance and Safety of a Second Generation Antimicrobial Graft in Abdominal Position
Role: lead
Investigation of Endothelium in Saphenous Vein Grafts
Role: collaborator
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Role: collaborator
The Boston Scientific ACCESS Trial
Role: lead
Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure
Role: lead
All 16 trials loaded